Insight

Megan E. Tesch: Estrogen levels in young patients on OFS treatment for breast cancer

Photo taken from Megan E. Tesch/X

Aug 3, 2024, 06:00

Megan E. Tesch: Estrogen levels in young patients on OFS treatment for breast cancer

Megan E. Tesch, Medical oncologist at Dana-Farber Cancer Institute, shared on X:

“What are the clinical implications of incomplete ovarian function suppression? In this study we evaluate estrogen levels in young patients on OFS treatment for breast cancer with ultrasensitive assays and correlate with outcomes.

‘Estrogen levels in young women with hormone receptor-positive breast cancer on ovarian function suppression therapy‘

Authors: Megan E. Tesch, Yue Zheng, Shoshana M. Rosenberg, Philip D. Poorvu, Kathryn J. Ruddy, Rulla Tamimi, Lidia Schapira, Jeffrey Peppercorn, Virginia Borges, Steven E. Come, Craig Snow, Shalender Bhasin Ann H. Partridge.⁦”

Source: Megan E. Tesch/X

Breast Cancer cancer Craig Snow Jeffrey Peppercorn Kathryn J. Ruddy Lidia Schapira Megan E. Tesch OncoDaily Oncology Philip D. Poorvu Rulla Tamimi Shalender Bhasin Ann H. Partridge Shoshana M. Rosenberg Steven E. Come Virginia Borges Yue Zheng

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage